| Machine Learning in Healthcare | Lifetime | 45 | GB 5 | 97.87 |
| Blood Pressure and Hypertension Studies | Lifetime | 579 | GB 54 | 98.36 |
| Cardiomyopathy and Myosin Studies | Lifetime | 402 | GB 50 | 97.82 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 125 | GB 11 | 96.38 |
| Heart Failure Treatment and Management | Lifetime | 487 | GB 33 | 98.21 |
| Artificial Intelligence in Healthcare | Lifetime | 139 | GB 8 | 96.00 |
| Lipoproteins and Cardiovascular Health | Lifetime | 532 | GB 52 | 97.84 |
| Cardiovascular Effects of Exercise | Lifetime | 523 | GB 46 | 97.17 |
| Genetic Associations and Epidemiology | Lifetime | 517 | GB 95 | 97.38 |
| Cardiovascular Disease and Adiposity | Lifetime | 714 | GB 49 | 96.63 |
| Cardiac Health and Mental Health | Lifetime | 704 | GB 58 | 95.81 |
| Healthcare Systems and Public Health | Lifetime | 901 | GB 8 | 89.62 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 754 | GB 29 | 89.08 |
| Medical Coding and Health Information | Lifetime | 438 | GB 70 | 78.59 |
| Sex and Gender in Healthcare | Lifetime | 1,000 | GB 64 | 66.43 |
| Machine Learning in Healthcare | 2021-2025 | 15 | GB 4 | 98.47 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 38 | GB 6 | 98.70 |
| Cardiovascular Effects of Exercise | 2021-2025 | 34 | GB 6 | 98.63 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 94 | GB 6 | 97.08 |
| Heart Failure Treatment and Management | 2021-2025 | 169 | GB 18 | 98.01 |
| Artificial Intelligence in Healthcare | 2021-2025 | 79 | GB 3 | 95.97 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 179 | GB 12 | 96.58 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 596 | GB 38 | 96.12 |
| Cardiac Health and Mental Health | 2021-2025 | 194 | GB 20 | 93.87 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 382 | GB 23 | 95.76 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 700 | GB 92 | 94.49 |
| Healthcare cost, quality, practices | 2021-2025 | 109 | GB 15 | 92.29 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 851 | GB 85 | 94.80 |
| Medical Coding and Health Information | 2021-2025 | 14 | GB 3 | 86.50 |
| ECG Monitoring and Analysis | 2021-2025 | 325 | GB 17 | 89.18 |
| Acute Myocardial Infarction Research | 2021-2025 | 941 | GB 68 | 89.78 |
| Viral Infections and Immunology Research | 2021-2025 | 700 | GB 41 | 85.06 |
| Chronic Disease Management Strategies | 2021-2025 | 892 | GB 169 | 83.97 |
| Congenital heart defects research | 2021-2025 | 613 | GB 50 | 77.28 |
| Medication Adherence and Compliance | 2021-2025 | 514 | GB 28 | 78.21 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 768 | GB 28 | 78.60 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 804 | GB 29 | 77.31 |
| Biomedical Text Mining and Ontologies | 2021-2025 | 546 | GB 43 | 73.83 |
| Sex and Gender in Healthcare | 2021-2025 | 341 | GB 36 | 62.74 |
| GDF15 and Related Biomarkers | 2021-2025 | 567 | GB 37 | 55.40 |
